Skip to content

"CLINICAL & QUALITY SUPPORT": what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

"CLINICAL & QUALITY SUPPORT"

BE 0757.626.220
NACE 72.109, Other research and development on natural sciences
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€12,579
2024 · €11,026+€1,554
Equity
€28,355
2024 · €45,776-€17,421
Cash
€9,551
2024 · €13,957-€4,406
Balance sheet total
€67,856
2024 · €58,116+€9,740

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€14,016

    up €14,016 (+75.1%), from €18,654 to €32,670

    of which Other amounts receivable: +€8,097

  • Cash -€4,406

    down €4,406 (-31.6%), from €13,957 to €9,551

    mainly Contributions, distributions and other (-€30,000) and Receivables within one year (-€14,016)

Equity and liabilities
  • Other debts +€30,000

    new in 2025: €30,000

  • Profit (loss) carried forward -€17,421

    down €17,421 (-39.3%), from €44,276 to €26,855

  • Trade debts -€1,884

    down €1,884 (-41.9%), from €4,492 to €2,608

  • Tax, wage and social debts -€955

    down €955 (-12.2%), from €7,848 to €6,893

    of which Taxes: -€1,462

Income statement
  • Gross operating margin +€1,533

    up €1,533 (+9.1%), from €16,931 to €18,464

  • Taxes +€353

    up €353 (+7.9%), from €4,460 to €4,813

  • Financial income +€211

    up €211 (+30.6%), from €690 to €901

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €11,026
Gross operating margin +€1,533
Other operating charges +€79
Financial income +€211
Financial charges +€84
Taxes -€353
Result 2025 €12,579
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€25,594
Investment €0
Financing -€30,000
Cash 2024 €13,957
Net result for the year +€12,579
Depreciation +€322
Receivables within one year -€14,016
Deferred charges and accrued income -€452
Trade debts -€1,884
Tax, wage and social debts -€955
Other debts +€30,000
Contributions, distributions and other -€30,000
Cash 2025 €9,551
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €58,116 €67,856 +€9,740 +16.8%
Fixed assets 21/28 €966 €644 -€322 -33.3%
Tangible fixed assets 22/27 €966 €644 -€322 -33.3%
Plant, machinery and equipment 23 €966 €644 -€322 -33.3%
Current assets 29/58 €57,150 €67,212 +€10,062 +17.6%
Amounts receivable after more than one year 29 €20,900 €20,900 = 0.0%
Other amounts receivable 291 €20,900 €20,900 = 0.0%
Amounts receivable within one year 40/41 €18,654 €32,670 +€14,016 +75.1%
Trade receivables 40 €9,949 €15,868 +€5,919 +59.5%
Other amounts receivable 41 €8,704 €16,802 +€8,097 +93.0%
Cash at bank and in hand 54/58 €13,957 €9,551 -€4,406 -31.6%
Deferred charges and accrued income 490/1 €3,639 €4,091 +€452 +12.4%
Total equity and liabilities 10/49 €58,116 €67,856 +€9,740 +16.8%
Equity 10/15 €45,776 €28,355 -€17,421 -38.1%
Contributions 10/11 €1,500 €1,500 = 0.0%
Profit (loss) carried forward 14 €44,276 €26,855 -€17,421 -39.3%
Amounts payable 17/49 €12,340 €39,501 +€27,161 +220%
Amounts payable within one year 42/48 €12,340 €39,501 +€27,161 +220%
Trade debts 44 €4,492 €2,608 -€1,884 -41.9%
Suppliers 440/4 €4,492 €2,608 -€1,884 -41.9%
Taxes, remuneration and social security 45 €7,848 €6,893 -€955 -12.2%
Taxes 450/3 €7,848 €6,387 -€1,462 -18.6%
Remuneration and social security 454/9 - €506 +€506
Other amounts payable 47/48 - €30,000 +€30,000
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €322 €322 = 0.0%
Other operating charges 640/8 €979 €900 -€79 -8.1%
Gross operating margin 9900 €16,931 €18,464 +€1,533 +9.1%
Operating profit (loss) 9901 €15,630 €17,242 +€1,612 +10.3%
Financial income 75/76B €690 €901 +€211 +30.6%
Recurring financial income 75 €690 €901 +€211 +30.6%
Financial charges 65/66B €835 €751 -€84 -10.1%
Recurring financial charges 65 €835 €751 -€84 -10.1%
Profit (loss) for the period before taxes 9903 €15,485 €17,392 +€1,907 +12.3%
Income taxes 67/77 €4,460 €4,813 +€353 +7.9%
Profit (loss) for the period 9904 €11,026 €12,579 +€1,554 +14.1%
Profit (loss) for the period to be appropriated 9905 €11,026 €12,579 +€1,554 +14.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.